Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease
暂无分享,去创建一个
Ralf Deichmann | Simon Baudrexel | Carola Seifried | Johannes C. Klein | Helmuth Steinmetz | Rüdiger Hilker | Thomas Deller | Lucas Nürnberger | Udo Rüb | R. Deichmann | R. Hilker | J. Klein | H. Steinmetz | S. Baudrexel | U. Rüb | C. Seifried | T. Deller | L. Nürnberger
[1] D J Brooks,et al. Clinical and [18F] dopa PET findings in early Parkinson's disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[2] Martyn N J Paley,et al. MRI assessment of basal ganglia iron deposition in Parkinson's disease , 2008, Journal of magnetic resonance imaging : JMRI.
[3] David N. Kennedy,et al. Automated Brainstem Co-registration (ABC) for MRI , 2006, NeuroImage.
[4] V. Uversky,et al. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.
[5] David J. Brooks,et al. A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson’s disease , 2001, Neurology.
[6] Makoto Sawada,et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains , 2003, Acta Neuropathologica.
[7] Simon B. Eickhoff,et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data , 2005, NeuroImage.
[8] R. Djaldetti,et al. The mystery of motor asymmetry in Parkinson's disease , 2006, The Lancet Neurology.
[9] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[10] N. Gelman,et al. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: Relation to estimated iron and water contents , 2001, Magnetic resonance in medicine.
[11] M. Graeber,et al. Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration , 2006, Acta Neuropathologica.
[12] M. Hariz,et al. Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization. , 2008, Brain : a journal of neurology.
[13] R. Turner,et al. Does Hypercapnia-Induced Cerebral Vasodilation Modulate the Hemodynamic Response to Neural Activation? , 2001, NeuroImage.
[14] K. Ray Chaudhuri,et al. Early Parkinson’s disease and non-motor issues , 2008, Journal of Neurology.
[15] Helmut Heinsen,et al. Brainstem pathology and non-motor symptoms in PD , 2010, Journal of the Neurological Sciences.
[16] P. Mcgeer,et al. Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.
[17] N. Pelc,et al. Brain motion: measurement with phase-contrast MR imaging. , 1992, Radiology.
[18] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[19] S. Kollias,et al. Duvernoy's Atlas of the Human Brain Stem and Cerebellum , 2009 .
[20] S. Holland,et al. NMR relaxation times in the human brain at 3.0 tesla , 1999, Journal of magnetic resonance imaging : JMRI.
[21] Yoshiharu Tamakawa,et al. The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings. , 2002, AJNR. American journal of neuroradiology.
[22] Werner Jaschke,et al. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. , 2006, Brain : a journal of neurology.
[23] R. Ordidge,et al. Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease , 1995, Neurology.
[24] E. S. Watkins,et al. Stereotaxic atlas of the human brainstem and cerebellar nuclei : a variability study , 1978 .
[25] Peter Riederer,et al. The relevance of iron in the pathogenesis of Parkinson’s disease , 2011, Journal of neurochemistry.
[26] M Hutchinson,et al. Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra , 1999, Journal of neurology, neurosurgery, and psychiatry.
[27] Daniela Berg,et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. , 2002, Archives of neurology.
[28] T. Foster,et al. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. , 1984, Medical physics.
[29] R. Ordidge,et al. Assessment of relative brain iron concentrations using T2‐weighted and T2*‐weighted MRI at 3 Tesla , 1994, Magnetic resonance in medicine.
[30] D. J. Brooks,et al. Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease , 2000, Journal of Neurology.
[31] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[32] J V Hajnal,et al. A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. , 2001, Neurology.
[33] Stephen D. Mayhew,et al. Brainstem functional magnetic resonance imaging: Disentangling signal from physiological noise , 2008, Journal of magnetic resonance imaging : JMRI.
[34] Marguerite Wieler,et al. Midbrain iron content in early Parkinson disease , 2008, Neurology.
[35] Alexander Gerhard,et al. In vivo imaging of microglial activation with [11C](R)‐PK11195 PET in corticobasal degeneration , 2004, Movement disorders : official journal of the Movement Disorder Society.
[36] Thomas E. Nichols,et al. Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.
[37] P D Griffiths,et al. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. , 2000, Brain : a journal of neurology.
[38] Paul M. Matthews,et al. MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study , 2009, NeuroImage.
[39] J Fiehler,et al. Age-Dependent Normal Values of T2* and T2′ in Brain Parenchyma , 2008, American Journal of Neuroradiology.
[40] M Hutchinson,et al. Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging. , 2000, AJNR. American journal of neuroradiology.
[41] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[42] T. Peters,et al. High‐resolution T1 and T2 mapping of the brain in a clinically acceptable time with DESPOT1 and DESPOT2 , 2005, Magnetic resonance in medicine.
[43] D. Yarnitsky,et al. Quantitative measurement of pain sensation in patients with Parkinson disease , 2004, Neurology.
[44] R. Deichmann,et al. Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles , 2009, Magnetic resonance in medicine.
[45] Daniela Berg,et al. Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[46] Michael Hutchinson,et al. On false negatives in MRI studies of Parkinson disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[47] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[48] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[49] P Riederer,et al. Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.
[50] Klaus Seppi,et al. An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism , 2005, Current opinion in neurology.
[51] Daniela Berg,et al. Iron metabolism in Parkinsonian syndromes , 2006, Movement disorders : official journal of the Movement Disorder Society.
[52] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[53] Michael Hutchinson,et al. Detection of Parkinson's disease by MRI: Spin‐lattice distribution imaging , 2008, Movement disorders : official journal of the Movement Disorder Society.
[54] Karl J. Friston. Testing for anatomically specified regional effects , 1997, Human brain mapping.
[55] R. Hauser,et al. Prevalence and treatment of non-motor symptoms in Parkinson's disease. , 2007, Parkinsonism & related disorders.
[56] A J Lees,et al. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[57] L. Bongiovanni,et al. Sympathetic skin response asymmetry in early stage idiopathic Parkinson's disease , 1999, Clinical Neurophysiology.
[58] Kiyoshi Morita,et al. Clinical significance of T1-weighted MR images following transient cerebral ischemia , 2006, Journal of the Neurological Sciences.
[59] M. B. Spraker,et al. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease , 2009, Neurology.
[60] Vasily L Yarnykh,et al. Actual flip‐angle imaging in the pulsed steady state: A method for rapid three‐dimensional mapping of the transmitted radiofrequency field , 2007, Magnetic resonance in medicine.
[61] Christine Preibisch,et al. Rapid single‐scan T 2* ‐mapping using exponential excitation pulses and image‐based correction for linear background gradients , 2009, Magnetic resonance in medicine.
[62] H Bratzke,et al. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. , 1998, Progress in brain research.
[63] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.
[64] Christine Preibisch,et al. Exponential excitation pulses for improved water content mapping in the presence of background gradients , 2008, Magnetic resonance in medicine.
[65] R. Brooks,et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. , 1999, Radiology.
[66] P. Riederer,et al. Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation? , 2000, Journal of Chemical Neuroanatomy.
[67] David Eidelberg,et al. Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease , 2008, The Journal of Neuroscience.